Introduction
It is well appreciated that lymphocytes continually recirculate during immune surveillance, moving from the blood into organized lymphoid tissues and subsequently returning to the blood via the lymphatics. 1 Similarly, lymphocytes and other leukocyte populations are recruited from the blood to sites of inflammation and tissue damage. Evidence from many groups supports a multi-step model of adhesive interactions and activation signals during the recruitment process [2] [3] [4] (Figure 1 ). Initially, marginated leukocytes tether via microvillous processes to the endothelium and engage in transient interactions that manifest as rolling as due to hemodynamic shear forces. Leukocytes then undergo a rapid activation step that upregulates integrin function and allows them to arrest and adhere firmly to the endothelium. Adherent leukocytes subsequently migrate across the endothelium, and can localize to distinct microenvironmental sites by integration and sequential (step-by-step) navigation to signals from multiple chemoattractant sources. 5 Tethering and rolling are usually mediated by the selectin family of adhesion molecules (Lselectin expressed constitutively on leukocytes, and P-selectin and E-selectin upregulated by activated endothelium), that bind to ligands modified with specific carbohydrate epitopes. 6, 7 Leukocyte adhesion is mediated by interactions of the integrin family of adhesion molecules [LFA-1 (αLβ2), Mac-1 (αMβ2), VLA-4 (α4β1), and LPAM-1 (α4β7)] with members of the immunoglobulin family of adhesion molecules (ICAM-1, ICAM-2, VCAM-1, and MAdCAM-1). 8, 9 However, in vitro and in vivo evidence shows that the α4-integrins (α4β1 and α4β7) can also support leukocyte tethering and rolling. [10] [11] [12] [13] One key to the participation of selectins and α4-integrins in tethering is their expression on microvillous processes on the surface of circulating cells. 10, 14 As integrins are normally expressed on leukocytes in a state that has low affinity for ligands, [15] [16] [17] [18] it is clear that they must become functionally upregulated to mediate firm adhesion. Several in vitro studies have demonstrated that cross-linking L-selectin on leukocytes or binding to E-selectin can upregulate integrin function, 19- CLA -E-selectin α4β1 -VCAM-1?
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The multistep model of leukocyte-endothelial interactions in the recognition and recruitment of leukocytes from the blood. The adhesive and activation steps that take place during the recruitment of naive lymphocytes to the lymph nodes and memory lymphocyte subsets to the skin and gut illustrate the sequential recruitment cascade. Each step in the cascade involves independent receptor-ligand interactions that can enhance specificity through combinatorial control of leukocyte recruitment.
that this interaction could provide the activation signal required for firm adhesion. However, this signal is not sufficient to initiate adhesion under physiological conditions: leukocytes have been shown to roll on P-selectin, E-selectin, and glycosylated L-selectin ligands, without upregulating adhesion to ICAM-1. 15, 22 Additionally, neutrophils and lymphocytes both exhibit rolling behavior in high endothelial venules (HEV) of lymphoid tissues, but only lymphocytes adhere, 23 suggesting that a more selective signal regulates adhesion. This review will focus on the role that chemokines play in mediating the specificity of the leukocyte recruitment paradigm through adhesion triggering and directed migration. We will review some of the mechanisms known to regulate these events, and highlight how these pathways operate during lymphocyte homing in vivo.
Chemokines and their receptors
The chemokines are a superfamily of about 50 low molecular weight chemotactic cytokines (8-14 kD) that bind to and signal through seven transmembrane-spanning G-protein-linked receptors expressed on leukocytes and other cell types. 24, 25 Chemokines share homologous sequences and can be subdivided into four main classes (C-C, C-X-C, C-X 3 -C and C) depending on the orientation of conserved cysteine residues in their amino acid sequences. The chemokine receptors preferentially signal through heterotrimeric G-proteins of the Gαi class as most responses are sensitive to inhibition with pertussis toxin (PTX). [26] [27] [28] However, in some studies PTX has not completely blocked chemokine responses, suggesting that some chemokine receptors may also couple to Gαq or Gα16 in certain cell types or under certain circumstances. 29, 30 The expression of chemokine receptors varies greatly among different leukocyte subsets. Furthermore, the chemokines they recognize are differentially expressed in tissues and inflammatory conditions. 25,31 Therefore, chemokines acting in combination with different adhesion receptors, have the potential to increase the specificity of leukocyte homing by providing an additional level of control through which cells home to tissue sites ( Figure 1 ).
Chemokine-induced changes in affinity and avidity
Chemokines induce rapid but transient increases in adhesion of leukocytes to immobilized integrin ligands. 17, 18, 32, 33 This can occur via two different mechanisms, upregulation of integrin affinity through conformational changes, or changes in integrin avidity which occur through integrin clustering. 16, [34] [35] [36] Chemokine-induced changes in integrin affinity can be observed by measuring the binding of soluble ICAM-1 and VCAM-1 to activated cells, 17, 18 or the binding of antibodies that act as ligand mimetics. 32, 36 However, it should be noted that chemokine-induced binding to soluble ligands varies in different cell types and with different integrins. For example, the chemokine SDF-1α induces rapid binding of soluble ICAM-1 to lymphocytes, 17 while very little binding to soluble VCAM-1 is observed. 18 In contrast, SDF-1α induces significant increases in the binding of soluble VCAM-1 to monocytes. 18 It is not clear what signaling pathways upregulate integrin affinity after chemokine stimulation, but the src kinase p56 lck has been implicated in the regulation of VLA-4 (α4β1) affinity. 37 Avidity changes through clustering of low affinity receptors can strengthen adhesion to immobilized integrin ligands. 16 This process requires proteasedependent release of integrins from cytoskeletal restraints in order to facilitate lateral mobility of integrins in the plasma membrane. 34, 35 Chemokines can induce rapid clustering of integrins, 17, 32 suggesting that chemokines induce increased lateral mobility of adhesion molecules in addition to affinity changes. Chemokine induced clustering of LFA-1 (αLβ2) can be blocked by inhibitors of phosphoinositide-3 kinase (PI3K) or the protease calpain, which have no affect on the ability of chemokine-stimulated lymphocytes to bind soluble ICAM-1. 17 This suggests that chemokine-induced changes in integrin affinity and avidity are regulated through different pathways.
The contribution of affinity and avidity changes to leukocyte adhesion appears to vary depending on the site density of the adhesive substrate. While chemokine-induced adhesion to low density ICAM-1 (<1500 sites µm −2 ) is inhibited by blocking PI3K or protease activity, adhesion to high density ICAM-1 (>3000 sites µm −2 ) is insensitive to these inhibitors. 17 This suggests that affinity changes are sufficient to mediate adhesion to high density ligands when the integrin does not need to move to encounter ligand, but chemokine-enhanced integrin mobility is required to facilitate adhesion to low density sites where ligands are spaced further apart. In vivo, lymphocyte adhesion to Peyer's patch HEV is insensitive to PI3K or protease inhibitors. 17 At 13 800 ± 1500 sites µm −2 , the ICAM-1 site density in Peyer's patch HEV is well in excess of the density at which lateral mobility becomes necessary to mediate adhesion. 17 However, it is possible that lateral mobility of integrins could play a role in the homing of lymphocytes to sites with lower ICAM-1 density.
Rapid adhesion triggering under flow
In order to examine the ability of chemokines to induce adhesion in the context of the multi-step recruitment cascade, many groups have utilized in vitro flow chamber assays that mimic blood flow. In contrast to static adhesion assays, selectin-mediated rolling interactions are important under flow conditions, as leukocytes will not interact on surfaces coated only with ICAM-1. 15, 22, 26 Lymphocytes and monocytes can also initiate selectin-independent low affinity rolling interactions with VCAM-1 or MAdCAM-1. 10, 11 Chemoattractant upregulated integrin function can then induce arrest and firm adhesion of rolling cells. Many chemokines can trigger adhesion of leukocyte subsets expressing the appropriate chemokine receptors. For example, IL-8 will induce adhesion of neutrophils which express CXCR1 and CXCR2; 38,39 MCP-1 will trigger the adhesion of monocytes through CCR2; 40 and eotaxin can trigger CCR3-dependent adhesion of eosinophils. 41 Adhesion of naive lymphocytes can be induced by the CCR7 ligands SLC and ELC, 26, 42 while different memory lymphocyte subsets will adhere in response to ligands for CXCR3 (IP-10 or Mig), 43 CCR4 (MDC or TARC), 44 CCR6 (MIP-3α), 26 or CCR1 and CCR5 (RANTES). 45 In most in vitro adhesion triggering studies, leukocytes tether and adhere almost immediately, 26, 38 while in vivo they often engage in significant rolling interactions before arresting and adhering firmly. 12, 23, 46 DiVietro et al. 39 addressed this issue by changing the site density of immobilized chemokine. As the concentration of immobilized chemokine was increased, the distance that cells rolled and time of interaction before arrest decreased significantly. This suggests that the neutrophils were integrating the chemokine signal and had to reach a threshold of activation before they would trigger adhesion. The observation that the rolling velocity of cells decreased as they rolled also suggests a gradual integration of signal. 39 Therefore it appears that adhesion can be triggered more quickly if the chemoattractant density is increased.
Chemokines on a stick
Most chemokines are produced as secreted molecules. However, there are two chemokines, fractalkine and CXCL-16, that are known to be expressed as transmembrane proteins attached to a mucin stock. 47, 48 Fractalkine can mediate rapid adhesion of CX 3 CR1 + NK cells, CD8 + T lymphocytes, and monocytes under conditions of shear flow. 49,50 However, unlike other chemokines, cells can tether and adhere directly to fractalkine in a PTX-independent manner. 49, 50 This effect requires intact chemokine as no adhesion is seen if the chemokine domain and mucin stock are immobilized separately or in trans. It is not known whether CXCL16 can act in the same manner, and it is unclear whether these chemokines can elicit direct adhesion of CX 3 CR1 + cells to endothelium in vivo.
Chemokine immobilization
In flow assays, chemokines can initiate leukocyte adhesion if they are coimmobilized on the surface, 26,38 or if they are added as soluble factors in the perfusion fluid. 39,40 However, it is unlikely that soluble chemoattractants secreted from localized areas in vivo would persist at the blood-endothelium interface due to the dilution factors induced by shear flow. Therefore, chemoattractants that bind to the endothelial surface would be most likely to promote leukocyte adhesion and migration. 51 This point is illustrated by the observations of Weber et al.: 52 TNFα-stimulated endothelial cells produced two chemokines, Groα which binds to the endothelium, and MCP-1 which is secreted into the supernatant without binding the endothelium. Under flow conditions, only Groα mediates monocyte adhesion to the endothelium, while the MCP-1 is diluted and washed away by fluid flow. As MCP-1 has been shown to induce monocyte adhesion under flow conditions when it is present homogeneously in the perfusion buffer, 40 this confirms that chemokine gradients from local sources are most efficient when immobilized on the endothelium, while soluble chemokines exposed to shear flow are dispersed and unable to mediate adhesion.
Many chemokines have been shown to bind to the surface of endothelial cells. 45, 53 As most have highly charged amino acid residues that can mediate binding to heparan sulfate and other glycosylaminoglycans (GAGs), [54] [55] [56] and heparinase treatments block binding of chemokines to endothelial cells, 52,57 this interaction is likely to facilitate the immobilization of chemokines on the endothelial surface. Another molecule that may immobilize chemokines on the endothelial surface is the Duffy antigen receptor for chemokines (DARC). This chemokine receptor is expressed on endothelium and red blood cells, and binds promiscuously to members of the CC and CXC classes of chemokines without activating intracellular signaling pathways. 58 However, it is not clear whether DARC facilitates presentation of chemokines on the endothelium. In fact, responses in DARC deficient mice suggest that this molecule could act to sequester chemokines and prevent them from activating leukocytes. 59 Activated endothelial cells can produce and bind a number of chemokines that mediate leukocyte arrest. 38,45,52 In addition, Middleton et al. 57 have shown that endothelial cells transport chemokines from the basolateral to luminal surface, indicating that chemokines produced in the tissues can also impact on leukocyte recruitment. IL-8 or RANTES injected into the skin accumulate at the basolateral surface of the endothelium. Instead of diffusing through endothelial cell junctions, the chemokines are transported through the endothelium in vesicles and presented on the apical surface to intravascular leukocytes. 57 A truncated IL-8 peptide that is unable to interact with heparan sulfate was not transported through the endothelium to the apical surface, implicating heparan sulfate in this transport process. 57 These authors also postulated that DARC could play a role in transport across the endothelium as the chemokines that could be transported to the apical surface of endothelial cells (IL-8 and RANTES) also bind to this promiscuous chemokine receptor. 57 In contrast, MIP-1α does not bind to DARC and was not transported across the endothelium even though it binds to heparin. 57 Chemokines, including SLC, ELC, IL-8, and MCP-1, can also be transferred from sites of injection or inflammation to the draining lymph nodes. [60] [61] [62] [63] This also appears to require binding to heparan sulfate, as SLC with a truncated carboxyl terminus does not accumulate in draining lymph nodes. 60 In the lymph node, transferred chemokines move from the subscapular sinus through a network of reticular conduits, 64 and can be transported across HEV to the luminal surface. 60, 61, 63 MCP-1 transported from the inflamed skin triggers monocytes to adhere in HEV and gain access to the lymphoid tissues, 63 where they could influence immune responses.
Lymphocyte homing to secondary lymphoid tissues
Recruitment of lymphocytes from the blood to secondary lymphoid tissues is directed by binding interactions at specialized HEV which express ICAM-1 and a number of glycosylated L-selectin ligands collectively known as peripheral node addressins (pNAd) (Figure 1 ). Lymphocytes roll on HEV in vivo, with approximately 25% of rolling cells becoming firmly adherent to the vessel wall. 23 It is important to note, that <1% of the cells adhere without rolling, demonstrating the importance of the multi-step process. In peripheral lymph node HEV, lymphocyte tethering and rolling are completely blocked by Lselectin antibodies, while the firm adhesion step can be blocked by antibodies against LFA-1 (αLβ2). 23 In the Peyer's patch however, lymphocyte homing has an additional adhesive component: α4β7 expressed on lymphocytes interacts with MAdCAM-1 to dramatically slow rolling (and can support some tethering and rolling even in the presence of L-selectin antibodies), while antibodies against α4β7, MAdCAM-1, or LFA-1 each block adhesion completely. 13 This suggests that α4β7/MAdCAM-1 interactions function as an essential 'bridge' between the tethering and firm adhesion steps in Peyer's patch HEV.
A spontaneous deletion in the functional coding region for two closely associated chemokines, SLC and ELC, 65, 66 results in a serious defect in the ability of normal naive T lymphocytes to home to secondary lymphoid organs in DDD/1-plt (paucity of lymph node T cells) mice. 67, 68 A targeted mutation in CCR7, the receptor for SLC and ELC, produces a similar phenotype. 69 Consistent with this data, T lymphocytes adhere primarily in HEV that stain with SLC ( Figure 2) . Furthermore, lymphocytes desensitized to SLC or ELC do not adhere in HEV of PLN or Peyer's patches. 60, 70 In contrast, Figure 2 . T lymphocytes localize primarily to Peyer's patch HEVs that express SLC. TRITC-labeled T lymphocytes (red) were allowed to accumulate in Peyer's patch HEVs for 10 min after iv. injection into normal animals. An Alexa TM 488-conjugated anti-SLC antibody (green) was then injected to illuminate SLC-expressing HEV segments. T lymphocytes preferentially accumulate in SLC + interfollicular areas but not in the follicular (F) areas. B lymphocytes accumulate preferentially in perifollicular areas that are often SLC negative (not shown) (20X objective).
desensitization with SDF-1α, the ligand for CXCR4, does not affect lymphocyte rolling or arrest in HEV.
While DDD/1-plt and CCR7 deficient mice are
deficient in the number of naive lymphocytes in secondary lymphoid tissues, they have significant numbers of memory T lymphocytes. 67, 69 It was proposed that this resulted from the recruitment of T lymphocytes from the tissues through the afferent lymphatics. However, it is also possible that other chemokines can mediate the recruitment of memory lymphocytes from the blood. For example, following sensitization to a contact allergen, MIP-1α and MIP-1β are produced in inflamed lymph nodes, and MIP-1β is transported to the surface of HEVs. 71 This is associated with increased recruitment of lymphocytes to the lymph node, and can be partially blocked by treating animals with neutralizing antibodies against these chemokines. Other chemokines that attract memory lymphocytes, including MDC, TARC, RANTES, Mig and MCP-1, are also expressed in the lymph node during inflammation, [72] [73] [74] and chemokines may also be transported from inflammatory tissue sites via the draining lymphatics and specialized reticular conduits. 64 Interestingly, B and T lymphocytes exhibit differences in lymphoid homing to secondary lymphoid organs even though they both respond to SLC and ELC in chemotaxis and adhesion assays. 75 While adhesion of both subsets can be blocked in vivo by PTX treatment, desensitization with SLC or ELC fails to block the arrest of B lymphocytes in HEV. 70 Furthermore, B and T lymphocytes accumulate in different areas of the Peyer's patch. T lymphocytes arrest primarily in interfollicular HEV which stain well with antibodies against SLC (Figure 2) , while B lymphocytes adhere primarily in perifollicular HEV which often lack SLC. 70 These findings are consistent with the observations that B lymphocytes home normally to the secondary lymphoid tissues of DDD/1-plt mice. 67, 68 B cells express CXCR5, the receptor for a chemokine (BLC/BCA-1) expressed primarily in B cell follicles. 76 However, B lymphocytes from CXCR5-deficient mice home normally to lymph nodes and Peyer's patches when transferred into wild type 77 or DDD/1-plt mice (Warnock and ECB, unpublished observation), suggesting that BLC/BCA-1 does not provide the signal for B cell adhesion in HEV of secondary lymphoid organs. The chemokines or other chemoattractants mediating CCR7-independent B cell recruitment to secondary lymphoid tissues remain to be determined.
Lymphocyte homing to skin versus intestinal sites
Memory lymphocyte populations exhibit selectivity in their homing to non-lymphoid tissues. The most clearly defined of these populations are a skin homing subset and a population that homes preferentially to intestinal sites (Figure 1 ). The specificity of these subsets for their target tissues derives from selective expression of specific adhesion molecules and chemokine receptors that recognize ligands that are differentially expressed at these tissue sites. The use of a limited number of adhesion molecules and chemokine receptors in various combinations can increase the potential diversity of specific homing responses.
Lymphocytes that home to inflamed skin express the cutaneous lymphocyte-associated antigen (CLA), a carbohydrate modification that recognizes Eselectin. 78, 79 CLA hi cells migrate in response to the chemokines TARC (a CCR4 ligand) and CTACK (a CCR10 ligand). 44, 80 As TARC is displayed on skin microvascular endothelium of patients with psoriasis and lichen planus, and can trigger adhesion of CLA + memory T lymphocytes to ICAM-1 under flow conditions, 44 it is likely to be involved in lymphocyte trafficking to the skin. CTACK is produced constitutively by epidermal keratinocytes, 80 suggesting that it may also play a role in the recruitment or localization of CLA + lymphocytes in the skin. Indeed, either CCR4 or CTACK support the homing of E-selectin-binding lymphocytes to inflamed skin in mice, while blocking both inhibits recruitment. 81 However, a formal demonstration of chemokine-induced adhesion triggering within the skin microvasculature awaits in situ microscopic studies.
Memory lymphocytes that migrate preferentially to intestinal sites express high levels of the α4β7-integrin compared with naive lymphocytes or systemic memory cells. 82 A population of these cells also express CCR9, the receptor for TECK, 83 which is expressed in the epithelium of the small intestine but not the colon. 84 Almost all lymphocytes in the small intestine, but few in the colon or other extra-lymphoid tissues express the TECK receptor, CCR9, 83,84 suggesting a specialized role for CCR9 and TECK in small intestinal immunity. Interestingly, CCR9 is expressed by many IgA antibody secreting cells (ASC), but not by IgM or IgG ASC, suggesting a mechanism for selective localization of IgA plasma cells to the gut. 85 It remains to be determined whether TECK mediates lymphocyte adhesion and/or diapedesis within the microvasculature of the small intestine, and what other factors can mediate lymphocyte recruitment to other intestinal sites.
Chemokines in transendothelial migration
While chemoattractants bound to the endothelial surface are most likely to promote leukocyte adhesion, it has been assumed that soluble or immobilized chemoattractant gradients across the endothelium could induce adherent cells to migrate from the vascular surface into the tissues. 51, 52 Cinamon et al. 86 have recently postulated that surface immobilized chemokines can facilitate transendothelial migration in the absence of chemoattractant gradients across the endothelium. Transendothelial migration required a higher concentration of bound chemokine than needed to elicit firm adhesion, and also required the presence of continual shear forces. A shear dependent enhancement of monocyte migration has also been reported, 52 but it was attributed to the release of soluble chemokine on both sides of the endothelium and the formation of a gradient only when shear forces removed chemokine from the apical surface. However, transendothelial migration in the absence of a chemotactic gradient as purported by Cinamon et al. 86 would suggest potential roles for additional factors including shear-dependent mechanoreceptors in facilitating the migration process. This concept could have important implications for the leukocyte recruitment process, and clearly requires more investigation.
Concluding remarks
The homing of leukocytes from the blood to the tissues needs to be a well controlled process to ensure the recruitment of the proper cells to the correct location at the right time. The use of chemokines at critical control points in the adhesion process allows for complex combinations of interactions to facilitate specific homing of specialized cell types to tissues. Although we have come a long way in our understanding of how leukocytes are recruited from the blood, there are many issues that still need to be resolved. The signaling pathways by which chemokines trigger leukocyte adhesion are poorly understood, as are the mechanisms regulating chemokine transport and presentation on endothelial surfaces. Current thinking about the requirement for chemokine gradients across the endothelium may need to be revised, and the role of shear forces in mediating migration in vivo need to be elucidated. In complex inflammatory conditions that involve multiple chemokines, it will be important to distinguish whether they act to trigger cell adhesion within the vasculature, induce migration across the endothelium, or act to localize cells to distinct locations within the tissues. 
